Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2011
06/21/2011CA2172392C Methods of inhibiting phagocytosis
06/18/2011CA2725650A1 Polyphenol compounds for inhibiting proteasome and uses thereof
06/18/2011CA2724086A1 Pharmaceutical compounds
06/16/2011WO2011072292A2 Phase changing formulations of rna and rna derivatives
06/16/2011WO2011072290A2 Targeted dendrimer-drug conjugates
06/16/2011WO2011072287A2 Method for late introduction of the (8r)-hydroxyl group in carbapenem beta-lactam antibiotic synthesis
06/16/2011WO2011072275A2 Agents and methods for treating ischemic and other diseases
06/16/2011WO2011072257A2 Amyloid binding agents
06/16/2011WO2011072244A1 Method of treatment of breast cancer with tamoxifen
06/16/2011WO2011072243A1 Histone acetyltransferase activators and uses thereof
06/16/2011WO2011072241A1 4 -oxo- ih -quinoline- 3 - carboxamides as modulators of atp -binding cassette transporters
06/16/2011WO2011072240A1 Drug delivery of temozolomide for systemic based treatment of cancer
06/16/2011WO2011072218A2 Stable formulations for lyophilizing therapeutic particles
06/16/2011WO2011072216A2 Treatment methods utilizing stem cell mobilizers and immunosuppressive agents
06/16/2011WO2011072207A1 Azocyclic inhibitors of fatty acid amide hydrolase
06/16/2011WO2011072181A2 Method of treating pancreatic cancer
06/16/2011WO2011072174A1 Therapeutically active compounds for use in the treatment of cancer characterized as having an idh mutation
06/16/2011WO2011072138A2 Therapeutic use of protein-polymer conjugates
06/16/2011WO2011072132A1 Methods of treating inflammatory conditions
06/16/2011WO2011072127A1 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
06/16/2011WO2011072091A1 Methods and compositions for treating diseases, disorders or injury of the cns
06/16/2011WO2011072082A2 Modulation of hsp47 expression
06/16/2011WO2011072012A2 Improved methods and compositions for vein harvest and autografting
06/16/2011WO2011071996A1 Faah inhibitors
06/16/2011WO2011071995A2 Compounds and methods of treating ocular disorders
06/16/2011WO2011071981A2 Anti-cytomegalovirus activity of artemisinin-derived dimers
06/16/2011WO2011071968A2 Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
06/16/2011WO2011071920A2 Promoting cycling of apoe4 isoform
06/16/2011WO2011071876A1 Stabilized aqueous dispersion of folpet analogues, method of preparing the same and composition thereof
06/16/2011WO2011071853A2 Parenteral formulation of clopidogrel
06/16/2011WO2011071849A2 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications
06/16/2011WO2011071840A1 Inhibitors of diacylglycerol acyltransferase
06/16/2011WO2011071821A1 Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea and salts thereof.
06/16/2011WO2011071805A1 4-methylpyrazole formulations
06/16/2011WO2011071758A1 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands
06/16/2011WO2011071730A1 Process for synthesis of intermediates useful for making substituted indazole and azaindazole compounds
06/16/2011WO2011071725A1 Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core
06/16/2011WO2011071716A1 Heterocyclic compounds containing an indole core
06/16/2011WO2011071692A1 Modulating cellular electrophysiology
06/16/2011WO2011071684A1 Oral rehydration solutions comprising dextrose
06/16/2011WO2011071672A1 Irinotecan immunoassay
06/16/2011WO2011071620A1 Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof
06/16/2011WO2011071570A1 Novel oxadiazole compounds
06/16/2011WO2011071565A1 Tgr5 agonists
06/16/2011WO2011071541A2 Cadherin modulatory agents
06/16/2011WO2011071535A2 Compositions and methods for inhibiting human host cell factors required for influenza virus replication
06/16/2011WO2011071491A1 Isotopologues of 4-[9-(tetrahydro-furan-3-yl)-8-(2, 4, 6- trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol
06/16/2011WO2011071453A1 Glycosaminoglycan mixtures
06/16/2011WO2011071400A1 Method and composition for preparing stable liquid formulations of paracetamol
06/16/2011WO2011071379A1 Micro-colloidal silicic acid / boric acid composition and a method of preparing a bioenhancing solution and powder
06/16/2011WO2011071371A1 Metabolic imprinting effects of structured lipids
06/16/2011WO2011071367A1 Metabolic imprinting effects of structured lipids
06/16/2011WO2011071194A1 SOLID DISPERSIONS CONTAINING 20-O-β-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL
06/16/2011WO2011071136A1 Therapeutic agent for fibromyalgia
06/16/2011WO2011071135A1 Oxazine derivative
06/16/2011WO2011071134A1 Prophylactic composition for influenza infection
06/16/2011WO2011071109A1 Fused heterocyclic compound having amino group
06/16/2011WO2011071095A1 Benzamide compound
06/16/2011WO2011071078A1 Aromatic compound, modification carrier that uses same and is used for synthesizing an oligonucleotide derivative, oligonucleotide derivative, and oligonucleotide construct
06/16/2011WO2011071059A1 T cell activation inhibitor, pharmaceutical composition containing same, and screening method for t cell activation inhibiting substance
06/16/2011WO2011071057A1 Pharmaceutical composition for treatment or prevention of alzheimer's disease containing sulfur-containing heterocyclic derivative
06/16/2011WO2011071048A1 Heteroarylcarboxylic acid ester derivative
06/16/2011WO2011071027A1 Rna interference molecule capable of inhibiting expression of socs3 protein encoded by socs3 gene, and use thereof
06/16/2011WO2011070781A1 Substituted aminothiazine derivative
06/16/2011WO2011070579A1 Methods of improving cognitive functions
06/16/2011WO2011070565A1 Glucans for treating or preventing food sensitivity
06/16/2011WO2011070541A1 Cysteine protease inhibitors
06/16/2011WO2011070539A1 Cysteine protease inhibitors
06/16/2011WO2011070444A2 Compositions and methods for treating friedreich's ataxia
06/16/2011WO2011070415A1 Novel therapeutic methods for treating inflammation and immune system disorders
06/16/2011WO2011070407A1 N-substituted deoxynojirimycin compounds for use in inhibiting osteoclastogenesis and/or osteoclast activation
06/16/2011WO2011070369A1 Inhibitors of hemopoietic cell kinase (p59-hck) and their use in the treatment of influenza infection
06/16/2011WO2011070368A1 Antiviral use of urea compounds
06/16/2011WO2011070361A1 Process and product
06/16/2011WO2011070299A1 Tri-substituted 9h-beta-carboline (or 9h-pyrido[3,4-b]indole) derivatives, preparation of same and therapeutic use thereof
06/16/2011WO2011070298A1 Di-substituted 9h-pyrido[3,4-b]indole derivatives, preparation of same and therapeutic use thereof
06/16/2011WO2011070253A1 Azabicyclo[3.1.0]hex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same
06/16/2011WO2011070252A1 Azabicyclo[3.2.0]hept-6-yl derivatives as antagonists of histamine h3 receptor
06/16/2011WO2011070251A1 Novel hexahydrocyclopenta[b]pyrrol derivatives, method for preparing same, and pharmaceutical compositions containing same
06/16/2011WO2011070250A1 Novel azabicyclo[3.2.0]hept-3-yl derivatives, method for preparing same, and pharmaceutical compositions containing same
06/16/2011WO2011070177A2 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators
06/16/2011WO2011070168A1 Pharmaceutical composition for treating cutaneous burns
06/16/2011WO2011070152A2 Novel antiviral compounds, which are aryl 3-deazauridine analogues at c3 position
06/16/2011WO2011070131A1 5-amino- 4-hydroxypentoyl amides
06/16/2011WO2011070125A1 Mucoadhesive buccal tablets for the treatment of orofacial herpes
06/16/2011WO2011070080A1 4- (azacycloalkyl) -benzene-1, 3 -diol derivatives as tyrosinase inhibitors and their synthesis and use thereof
06/16/2011WO2011070066A1 Fty720 halogenated derivatives
06/16/2011WO2011070049A1 Endothelin inhibitors for the treatment of rapidly progressive glomerulonephritis
06/16/2011WO2011070039A1 Spiro indole - cyclopropane indolinones useful as ampk modulators
06/16/2011WO2011070030A1 Heterocyclic sulfonamide derivatives
06/16/2011WO2011070029A1 Amino oxazine derivatives
06/16/2011WO2011069995A1 Novel 24-membered cyclooctadepsipeptides from fungal strains and their use as anthelmintics or endoparasiticides
06/16/2011WO2011069990A1 Pharmaceutical or veterinary antiviral compositions
06/16/2011WO2011069962A1 Bibw 2992 for use in the treatment of triple negative breast cancer
06/16/2011WO2011069958A2 Low caloric fat replacers
06/16/2011WO2011069951A1 Imidazolidinedione derivatives
06/16/2011WO2011069944A1 Crystalline {(3s)-3-[({1-[(2r)-2-carboxy-4-(1-naphthyl)butyl]cyclopentyl}-carbonyl)amino]-2-oxo-2,3,4,5-tetrahydro-1h-1benzazepin-1-yl}acetic acid, its preparation and use
06/16/2011WO2011069934A1 2-amino-5, 5-difluoro-5, 6-dihydro-4h-oxazines as bace 1 and/or bace 2 inhibitors
06/16/2011WO2011069932A1 Novel therapeutic uses for an ornithine alpha-ketoglutarate complex
06/16/2011WO2011069921A1 Sucrose octasulfates of zinc, the preparation of same and the pharmaceutical and cosmetic uses thereof
1 ... 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 ... 7860